JCO Oncology Practice Podcast

by Robert S. Miller, MD. Dr. Douglas Blayney reviews some of the research and presentations from the first ASCO Quality Care Symposium held in San Diego (Nov. 30 - Dec. 1, 2013), and covered in the special May 2013 issue of the JOP.

By Robert S. Miller, MD. Michael Neuss and Martha Polovich discuss the recent updates to the ASCO/ONS chemotherapy administration standards, focusing on the safe administration and management of oral chemotherapy.

by Robert S. Miller, MD. Medical oncologists Mike Thompson and Don Dizon join Claire Johnston, social media manager at ASCO, in a discussion of best practices in using social media for patient education, promotion of clinical trials, and professional networking for oncologists.

by Robert S. Miller, MD. Dr. Anupama Kurup, Chair-Elect of the ASCO Clinical Practice Committee, discusses some early findings from ASCO's recent census and survey of oncology practices in the U.S.

by Robert S. Miller, MD. Dr. Joseph Herman and Dr. Amol Narang of Johns Hopkins discuss how direct-to-consumer advertising is being used by some providers and medical centers to aggressively promote stereotactic radiation therapy.

by Robert S. Miller, MD. Elaine Towle and Tom Barr from Oncology Metrics discuss their annual National Practice Benchmark Report, and looking at 2011 data, revise last year's predictions and project trends for the next 3 years.

By Robert S. Miller, MD. Linda Parreco, RN, MS of the NCI describes some evidence-based communication strategies that can be used to improve clinical trial discussions with patients.

by Robert S. Miller, MD. Dr. Jeffrey Peppercorn of Duke discusses the ethical issues raised when a patient declines potentially curative therapy for breast cancer.

By Robert S. Miller, MD. Deborah K. Mayer, PhD, RN from UNC discusses what she and her colleagues learned from interviews and focus groups with cancer survivors and primary care physicians on the subject of survivorship and transitions in care.

by Robert S. Miller, MD. Dr. Jessica Hwang discusses a retrospective cohort study from M.D. Anderson looking at rates and predictors of hepatitis B virus screening in patients undergoing chemotherapy or other immunosuppressive therapy.

by Robert S. Miller, MD. Dr. Nathan Pennell discusses some of the interesting obstacles he encountered when trying to prescribe crizotinib for 3 patients with ALK positive non-small cell lung cancer in the first few weeks following FDA approval in 2011.

By Robert S. Miller, MD. Dr. John Sprandio discusses how his Philadelphia-area oncology practice became a level III patient-centered medical home and the impact this transformation had on the quality of care delivery and costs.

by Robert S. Miller, MD. Dr. John Cox and Mr. Ronald Barkley discuss the October 2011 Cancer Center Business Summit and what the concept of an accountable care organization might mean to oncology.

by Robert S. Miller, MD. Co-authors Lori Wiener and Melinda Merchant discuss how Facebook and other forms of social media can affect the relationship between patients and oncology professionals.

by Robert S. Miller, MD. Dr. Jessica Hwang discusses a pilot project in which she and fellow investigators from The University of Texas MD Anderson Cancer Center studied ways to improve clinic efficiency and decrease patient waiting times in the outpatient infusion center.

by Robert S. Miller, MD. Dr. Joseph Jacobson and Dr. Therese Mulvey discuss the recent updates to the 2009 ASCO/ONS chemo administration safety standards, now inclusive of the inpatient setting.

by Robert S. Miller, MD. Dr. Amy Abernethy from Duke discusses the challenges and promises of integrating palliative care and oncology

by Robert S. Miller. Executive Director Jose Gonzalez and consultant Patricia Falconer discuss how ANCO put together a consultation service for its members in 2009-10 to assess practice financial health and prescribe changes to practice management to enhance economic viability.

by Robert S. Miller. Elaine Towle and Tom Barr from Oncology Metrics discuss their annual National Practice Benchmark Report and review practice trends from 2005-2010.

by Robert S. Miller. Dr. Miller discusses highlights from the special series in the July 2011 issue of the Journal of Oncology Practice on Electronic Health Records in oncology.

by Robert S. Miller. Dr. Peter Yu, guest editor for the JOP Special Series "Electronic Health Records in Oncology," discusses the Federal meaningful use incentives and their applicability to oncologists.

by Robert S. Miller. Dr. John Quillin and Dr. Tom Smith of VCU discuss the role of DNA banking in dying patients with cancer and how few physicians are doing it.

by Robert S. Miller. Laurence Heifetz, M.D. discusses the successes and barriers he faced in establishing a cancer program in the Lake Tahoe area of California.

by Robert S. Miller. Kristen Cavanaugh, ACNP-BC discusses promising research showing that, for women who have undergone axillary lymph node dissection, exercise involving the affected arm does not seem to increase the risk of lymphedema.

by Robert S. Miller. Dr. Gabriel Hortobagyi discusses the 2011 update of the ASCO guideline on the use of bone-modifying agents in patients with metastatic breast cancer.